NCT01370434View on ClinicalTrials.gov

Two Cycles of PAD Combination by AHCT in MM

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Multiple Myeloma
Interventions
DRUG

PAD combination

"* Bortezomib 1.3 mg/m2/d iv on D 1, 4, 8, 11~* Doxorubicin 9 mg/m2/d iv on D 1-4~* Dexamethasone 40mg/d po or iv on D1-4, 8-11"

Trial Locations (1)

138-736

Asan Medical Center, Seoul

All Listed Sponsors
lead

Cooperative Study Group A for Hematology

NETWORK

NCT01370434 - Two Cycles of PAD Combination by AHCT in MM | Biotech Hunter | Biotech Hunter